Jeff Yass’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-2,050
| Closed | -$232K | – | 10127 |
|
|
2020
Q1 | $232K | Buy |
+2,050
| New | +$234K | ﹤0.01% | 8427 |
|
|
2019
Q2 | – | Sell |
-1,988
| Closed | -$266K | – | 10213 |
|
|
2019
Q1 | $266K | Sell |
1,988
-1,050
| -35% | -$148K | ﹤0.01% | 7409 |
|
|
2018
Q4 | $559K | Buy |
+3,038
| New | +$489K | ﹤0.01% | 5804 |
|
|
2018
Q1 | – | Sell |
-1,975
| Closed | -$348K | – | 9311 |
|
|
2017
Q4 | $348K | Sell |
1,975
-950
| -32% | -$169K | ﹤0.01% | 7337 |
|
|
2017
Q3 | $481K | Buy |
2,925
+1,075
| +58% | +$194K | ﹤0.01% | 6572 |
|
|
2017
Q2 | $359K | Buy |
1,850
+275
| +17% | +$60K | ﹤0.01% | 7245 |
|
|
2017
Q1 | $351K | Sell |
1,575
-213
| -12% | -$50.3K | ﹤0.01% | 7102 |
|
|
2016
Q4 | $500K | Buy |
1,788
+275
| +18% | +$75.2K | ﹤0.01% | 7003 |
|
|
2016
Q3 | $383K | Buy |
1,513
+900
| +147% | +$239K | ﹤0.01% | 6530 |
|
|
2016
Q2 | $204K | Sell |
613
-12,525
| -95% | -$3.96M | ﹤0.01% | 7569 |
|
|
2016
Q1 | $4.58M | Sell |
13,138
-1,625
| -11% | -$565K | ﹤0.01% | 2419 |
|
|
2015
Q4 | $3.39M | Sell |
14,763
-23,850
| -62% | -$6.13M | ﹤0.01% | 3075 |
|
|
2015
Q3 | $11.9M | Buy |
38,613
+27,238
| +239% | +$6.43M | 0.01% | 1663 |
|
|
2015
Q2 | $2.74M | Buy |
11,375
+9,762
| +605% | +$2.42M | ﹤0.01% | 4029 |
|
|
2015
Q1 | $445K | Sell |
1,613
-2,950
| -65% | -$903K | ﹤0.01% | 7309 |
|
|
2014
Q4 | $1.68M | Buy |
4,563
+2,640
| +137% | +$1.1M | ﹤0.01% | 4792 |
|
|
2014
Q3 | $926K | Sell |
1,923
-3,277
| -63% | -$1.74M | ﹤0.01% | 6069 |
|
|
2014
Q2 | $2.96M | Buy |
5,200
+3,577
| +220% | +$2.46M | ﹤0.01% | 3937 |
|
|
2014
Q1 | $1.16M | Buy |
+1,623
| New | +$1.08M | ﹤0.01% | 5252 |
|
Other funds holding BIS
Jeff Yass's BIS Position: Q2 2026 in Review
Jeff Yass increased its ProShares UltraShort NASDAQ Biotechnology (BIS) stake by 35% in Q2 2026, buying an estimated $191K and bringing the position to 44,359 shares worth $603K. The position accounts for ﹤0.01% of the portfolio, ranked #9460.
Jeff Yass first reported a position in BIS in Q2 2013 and has held it in 36 quarters since. The position peaked at $3.63M in Q3 2015. 2 funds tracked by Wall St. Rank hold BIS as of Q2 2026.
- Jeff Yass held 44,359 shares of ProShares UltraShort NASDAQ Biotechnology worth $603K as of Q2 2026.
- Jeff Yass bought 11,385 ProShares UltraShort NASDAQ Biotechnology shares in Q2 2026, an estimated $191K.
- ProShares UltraShort NASDAQ Biotechnology made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #9460 holding.
- Jeff Yass first reported a position in ProShares UltraShort NASDAQ Biotechnology in Q2 2013 and has held it in 36 quarters since.
- Jeff Yass's ProShares UltraShort NASDAQ Biotechnology position peaked at $3.63M in Q3 2015.
- 2 funds tracked by Wall St. Rank held ProShares UltraShort NASDAQ Biotechnology as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.